ISRCTN18173987已完成不适用
A trial to compare radiotherapy alone with radiotherapy followed by chemotherapy in the treatment of non-Hodgkin's lymphoma
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 15-65 years
- •2. Proven non-Hodgkin's disease with good pathology involving nodes, Waldeyer's ring is also included provided that nodes are also involved
- •3. Stage I or II
排除标准
- •Patients with abdominal nodes only are excluded
研究者
相似试验
已完成
不适用
A randomised trial of radiotherapy alone versus three cycles of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) chemotherapy plus radiotherapy versus six cycles of CHOP chemotherapy plus radiotherapy for early stage aggressive non-Hodgkin's lymphomaon-Hodgkin's lymphomaNon-Hodgkin's lymphomaCancerISRCTN55593137Cancer Research UK (CRUK) (UK)
已完成
不适用
Comparison of radical radiotherapy with or without chemotherapy for poor prognosis carcinoma of cervixCervix cancerCervixCancerISRCTN38929731Cancer Research UK (CRUK) (UK)
已完成
不适用
Phase I trial evaluating combined radiotherapy with Panitumumab (Vectibix®) in patients with muscle invasive transitional cell carcinoma of the bladder10004994Bladder carcinomabladder cancerNL-OMON34833Antoni van Leeuwenhoek Ziekenhuis31
招募中
2 期
A phase II study of combination of radiotherapy and Atezolizumab/nab-paclitaxel for inoperable or recurrent PD-L1 positive triple negative breast cancerinoperable or recurrent PD-L1 positive triple negative breast cancerJPRN-jRCTs021210010Suzuki Yoshiyuki20
进行中（未招募）
1 期
Phase III intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with concomitant and adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma. - CodeletedEUCTR2008-007295-14-ATEORTC488